Search - tctmd.com

Displaying 101 - 120 of 580

Sort: Relevancy | Date

VA Medical Centers’ Quality Measures for TAVR Pay Off

News Daily News

VA Medical Centers’ Quality Measures for TAVR Pay Off

August 30, 2019

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

Aborted TAVR Procedures Are Waning in the US

News Daily News

Aborted TAVR Procedures Are Waning in the US

August 28, 2019

FDA Expands TAVR Indication to Low-Risk Patients

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

FDA Approves Lotus Edge, Ushering Third Device Into US Market

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

April 24, 2019

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

April 03, 2019

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

News Daily News

Lotus Maintains Good Safety, Efficacy at 2 Years, Though Questions Persist Over Permanent Pacing

Yael L. Maxwell

March 01, 2019

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

February 19, 2019

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

February 14, 2019

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

News Daily News

Is There a Volume-Outcome Relationship With Newer TAVR Valves? Maybe Not, Registry Suggests

January 30, 2019

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

News Daily News

FDA Clears Next-Generation Sapien 3 Ultra TAVR Valve

January 02, 2019

Better TAVR Outcomes With More Experienced Operators: New York Database

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

November 20, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.